Atimos (formoterol hydrofluoroalkane inhaler) / Chiesi, Novartis - LARVOL DELTA

Parameterization of H2SO4 and organic contributions to volatile PM in aircraft plumes at ground idle. (PubMed, J Air Waste Manag Assoc) - "While vPM is not currently a part of engine emissions certificationregulations, vPM is used in aviation environmental impact assessments and forair quality modeling in and around airports...These estimatescan be used to develop inventories and provide a better estimate of total PMemission for most aviation engines. Its use in international regulatory toolscan inform possible future regulatory actions regarding vPM."

Journal

Optimal Type of Inhaler in Cough Variant- or Cough Predominant Asthma (clinicaltrials.gov) - P=N/A | N=22 | Completed | Sponsor: Medical University of Warsaw | Recruiting ➔ Completed

Trial completion • Asthma • Cough • Immunology • Pulmonary Disease • Respiratory Diseases

Optimal Type of Inhaler in Cough Variant- or Cough Predominant Asthma (clinicaltrials.gov) - P=N/A; N=22; Recruiting; Sponsor: Medical University of Warsaw; Trial completion date: Dec 2020 ➔ Feb 2022; Trial primary completion date: Oct 2020 ➔ Dec 2021

Clinical • Trial completion date • Trial primary completion date • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases

Optimal Type of Inhaler in Cough Variant- or Cough Predominant Asthma (clinicaltrials.gov) - P=N/A; N=22; Recruiting; Sponsor: Medical University of Warsaw; Trial completion date: Feb 2020 ➔ Dec 2020; Trial primary completion date: Dec 2019 ➔ Oct 2020

Clinical • Trial completion date • Trial primary completion date • Asthma • Immunology • Respiratory Diseases

Optimal Type of Inhaler in Cough Variant- or Cough Predominant Asthma (clinicaltrials.gov) - P=N/A; N=22; Recruiting; Sponsor: Medical University of Warsaw

Clinical • New trial

"@ValleAlfonso esto es una propuesta muy solida sobre lo que debatimos en la reunion de consenso @varrarte @Carol_O_C @MaydePablo . Y con dibujos!!!!" (@paolabel_cardio)